Nephros, Inc.
NEPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $50,195 | $43,356 | $18,233 | $15,500 |
| - Cash | $5,171 | $5,074 | $4,081 | $3,760 |
| + Debt | $1,154 | $1,241 | $1,327 | $1,411 |
| Enterprise Value | $46,178 | $39,523 | $15,479 | $13,151 |
| Revenue | $4,764 | $4,419 | $4,877 | $3,870 |
| % Growth | 7.8% | -9.4% | 26% | – |
| Gross Profit | $2,915 | $2,795 | $3,154 | $2,475 |
| % Margin | 61.2% | 63.2% | 64.7% | 64% |
| EBITDA | $374 | $282 | $598 | $400 |
| % Margin | 7.9% | 6.4% | 12.3% | 10.3% |
| Net Income | $337 | $237 | $558 | $349 |
| % Margin | 7.1% | 5.4% | 11.4% | 9% |
| EPS Diluted | 0.03 | 0.022 | 0.053 | 0.033 |
| % Growth | 37% | -58.4% | 58.9% | – |
| Operating Cash Flow | $99 | $994 | $322 | $1,304 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $99 | $994 | $322 | $1,304 |